Lung-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study

被引:70
作者
Floratos, DL [1 ]
Kiemeney, LALM [1 ]
Rossi, C [1 ]
Kortmann, BBM [1 ]
Debruyne, FMJ [1 ]
de la Rosette, JJMCH [1 ]
机构
[1] Univ Med Ctr, Dept Urol, Nijmegen, Netherlands
关键词
prostatic hyperplasia; fever; transurethral resection of prostate;
D O I
10.1016/S0022-5347(05)66343-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluate the durable effect of high-energy transurethral microwave thermotherapy and transurethral prostatic resection for treatment of patients with lower urinary tract symptoms suggestive of bladder outflow obstruction. Materials and Methods: Between January 1996 and March 1997, 155 patients with lower urinary tract symptoms suggestive of bladder outflow obstruction were randomized to receive transurethral microwave thermotherapy (Prostatron* device and commercial software) (82) or undergo transurethral prostatic resection (73). Initial patient evaluation was performed according to international standards. Patients were followed annually with the International Prostate Symptom Score (I-PSS) and uroflowmetry (maximum flow rate). The Kaplan-Meier survival analysis was used to calculate the cumulative risk of re-treatment, adjusted for loss to followup. Results: A total of 78 patients received transurethral microwave thermotherapy and 66 underwent transurethral prostatic resection. Median followup was 33 months. In the thermotherapy group mean maximum urinary flow rate improved from 9.2 ml. per second at baseline to 15.1, 14.5 and 11.9 ml. per second at 1, 2 and 3 years, and mean I-PSS decreased from 20 to 8, 9, and 12, respectively. In the resection group the corresponding numbers for maximum urinary flow rate were 7.8, 24.5, 23.0 and 24.7 ml. per second at 1, 2 and 3 years, and for I-PSS were 20, 3, 4 and 3, respectively. At 36 months, 14 patients in the thermotherapy and 8 from the resection groups underwent re-treatment, and the cumulative risk was 19.8% (95% confidence interval 10.4%, to 29.3% and 12.9% (4.5% to 21.3%), respectively (p = 0.28). Conclusions: Transurethral microwave thermotherapy and transurethral prostatic resection achieve durable improvement in patients with lower urinary tract symptoms suggestive of bladder outflow obstruction, while the magnitude of improvement is higher with resection. The repeat thermotherapy is based on failure of therapy whereas repeat resection is based on complications of therapy.
引用
收藏
页码:1533 / 1538
页数:6
相关论文
共 24 条
[1]   Transurethral microwave thermotherapy (Prostatron(TM) version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: A randomized, controlled, parallel study [J].
Ahmed, M ;
Bell, T ;
Lawrence, WT ;
Ward, JP ;
Watson, GM .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (02) :181-185
[2]  
[Anonymous], AHCPR PUBLICATION
[3]   Immediate and postoperative complications of transurethral prostatectomy in the 1990s [J].
Borboroglu, PG ;
Kane, CJ ;
Ward, JF ;
Roberts, JL ;
Sands, JP .
JOURNAL OF UROLOGY, 1999, 162 (04) :1307-1310
[4]   3-YEAR FOLLOW-UP OF URINARY SYMPTOMS AFTER TRANSURETHRAL RESECTION OF THE PROSTATE [J].
BRUSKEWITZ, RC ;
LARSEN, EH ;
MADSEN, PO ;
DORFLINGER, T .
JOURNAL OF UROLOGY, 1986, 136 (03) :613-615
[5]  
D'Ancona FCH, 1998, BRIT J UROL, V81, P259
[6]  
D'Ancona FCH, 1998, BRIT J UROL, V82, P808
[7]   High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms [J].
dAncona, FCH ;
Francisca, EAE ;
Debruyne, FMJ ;
delaRosette, JJMCH .
JOURNAL OF ENDOUROLOGY, 1997, 11 (04) :285-289
[8]   Current status of thermotherapy of the prostate [J].
delaRosette, JJMCH ;
DAncona, FCH ;
Debruyne, FMJ .
JOURNAL OF UROLOGY, 1997, 157 (02) :430-438
[9]   High-energy transurethral microwave thermotherapy: A thermoablative treatment for benign prostatic obstruction [J].
deWildt, MJAM ;
Debruyne, FMJ ;
delaRosette, JJMCH .
UROLOGY, 1996, 48 (03) :416-423
[10]   Transurethral microwave thermotherapy for benign prostatic hyperplasia - experience with the Prostcare [J].
Eliasson, T ;
Terio, H ;
Damber, JE .
WORLD JOURNAL OF UROLOGY, 1998, 16 (02) :109-114